BPMX - BioPharmX Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
1/30/2019
1/30/2018
1/30/2017
1/30/2016
Assets
Current Assets
Cash
Cash And Cash Equivalents
3,069
7,576
6,501
4,039
Short Term Investments
-
-
-
-
Total Cash
3,069
7,576
6,501
4,039
Net Receivables
4
7
4
7
Inventory
0
10
38
100
Other Current Assets
-
-
0
0
Total Current Assets
3,385
7,981
6,827
4,431
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
325
243
202
304
Accumulated Depreciation
-177
-134
-82
-88
Net property, plant and equipment
148
109
120
216
Equity and other investments
-
-
-
-
Goodwill
-
-
-
-
Intangible Assets
-
-
0
119
Other long-term assets
121
-
154
85
Total non-current assets
269
109
274
420
Total Assets
3,654
8,090
7,101
4,851
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
-
-
Accounts Payable
1,363
1,376
2,551
1,777
Taxes payable
-
-
-
-
Accrued liabilities
934
1,595
1,165
750
Deferred revenues
0
8
11
19
Other Current Liabilities
-
-
0
182
Total Current Liabilities
2,297
2,979
3,727
2,797
Non-current liabilities
Long Term Debt
-
-
-
-
Deferred taxes liabilities
-
-
-
-
Deferred revenues
-
-
-
-
Other long-term liabilities
59
-
0
-
Total non-current liabilities
59
39
403
0
Total Liabilities
2,356
3,018
4,130
2,797
Stockholders' Equity
Common Stock
218
160
1,583
25
Retained Earnings
-78,534
-61,278
-44,638
-26,232
Accumulated other comprehensive income
-
-
-
-
Total stockholders' equity
1,298
5,072
2,971
2,054
Total liabilities and stockholders' equity
3,654
8,090
7,101
4,851